Discreet, evidence-based care for Pennsylvania women — HSDD, perimenopause, menopausal hormone therapy, low-dose testosterone for women, and vaginal estrogen — delivered by clinicians licensed in Pennsylvania.
Our providers are licensed by the Pennsylvania State Board of Medicine for comprehensive telehealth services statewide.
Hypoactive sexual desire disorder affects about 1 in 10 adult women. Treatable with FDA-approved Addyi or Vyleesi, low-dose testosterone, and addressing modifiable contributors like SSRIs and contraceptive choice.
Modern menopausal hormone therapy — typically transdermal estradiol with cyclic or continuous progesterone — for hot flashes, sleep disruption, libido changes, and mood symptoms.
Local vaginal estrogen, DHEA inserts (prasterone), and ospemifene for genitourinary symptoms with very low systemic absorption.
Off-label and supported by international guidelines for postmenopausal HSDD. Carefully titrated based on baseline labs, with quarterly monitoring.
Pennsylvania has comprehensive telehealth laws that support virtual care while maintaining quality and safety standards.
Pennsylvania's extensive pharmacy network from Philadelphia to Pittsburgh and throughout rural areas ensures prescription access.
Visits, intake forms, and lab results are protected health information. Medication ships in plain, unmarked packaging anywhere in Pennsylvania. If you choose cash-pay, no insurance EOB is sent to your household.